IT Versione italiana

scientific meetings » 14-ICML - LUGANO 2017


Malignant lymphomas: focus on the new treatment modalities based on immunotherapy

From 14.06.2017 to 17.06.2017    Lugano

Since 2011, the ICML conference has taken place in Lugano every two years with the increasing participation of specialists in lymphomas and related areas. The dominant theme of this edition was immunotherapy, thanks to the presentation of a great amount of clinical data, in particular on new treatments based on CAR-T Cells.



interviews

[en] Innovative therapies against lymphoma at the 14-ICML conference
Prof. Franco Cavalli
[en] The interaction between basic biology and clinical treatment
Prof. Jonathan Friedberg
[en] Relapsed/refractory B-cell malignancies: cerdulatinib ph. 2 study
Dr. Paul A. Hamlin
[en] Immunotherapy: useful information from lung cancer treatment
Prof. Rolf Stahel
[en] Chronic lymphocytic leukemia: a new class of agents and a chemo-free approach
Prof. Davide Rossi
[en] Cooperating to improve the survivorship and patient quality of life
Dr. Margaret Foti
[it] Linfoma primario del mediastino: stadiazione migliore con 18-FDG PET-CT
Dott. Luca Ceriani


Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK